Funding
Series B · Biotech

Inocras raises $31m Series B for precision oncology

NDS Corporation, Aimed Bio, IMM Investment and other investors participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Inocras raised $31 million in Series B financing on August 3. Participants included NDS Corporation, Aimed Bio, IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT&Investment, Woori Investment & Securities, Shinhan Securities, DSC Investment, Dunamu & Partners and InterVest. The company provides whole-genome sequencing and bioinformatics for precision oncology.

Funding history

Series B · This round$31M

Sources

  1. Inocrasprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related